Latest On Homology Medicines, Inc (FIXX):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-11 19:45 EST | News | Homology Medicines GAAP EPS of -$0.50 beats by $0.04, revenue of $0.8M misses by $0.21M | N/A |  |
| 2023-03-10 08:10 EST | News | Homology Medicines GAAP EPS of -$0.60 misses by $0.07, revenue of $0.82M misses by $0.1M | N/A | |
| 2023-03-09 16:37 EST | News | Homology Medicines gets new chief medical officer | N/A | |
| 2022-11-11 09:56 EST | News | Homology Medicines GAAP EPS of -$0.59 misses by $0.11, revenue of $0.80M misses by $0.16M | N/A | |
| 2022-09-07 01:48 EST | News | Homology Medicines appoints new CEO, chairperson | N/A | |
| 2022-08-16 07:47 EST | News | Homology Medicines GAAP EPS of -$0.51 beats by $0.04, revenue of $0.8M misses by $0.31M | N/A | |
| 2022-07-05 13:17 EST | News | Homology announces peer-reviewed preclinical data publication on its AAVHSC16 capsid | N/A | |
| 2022-06-14 00:18 EST | News | FDA lifts clinical hold on Homology Medicines' phenylketonuria trial | N/A | |
| 2022-05-17 06:38 EST | News | Homology Medicines GAAP EPS of $1.59 beats by $1.52 | N/A | |
| 2022-04-06 15:37 EST | News | Homology stock falls 11% as Canaccord cuts price target citing potentially prolonged clinical hold | N/A | |
| 2022-03-24 11:15 EST | News | Homology Medicines GAAP EPS of -$0.59 beats by $0.02, revenue of $0.8M misses by $0.1M | N/A | |
| 2022-03-11 11:09 EST | News | Oxford Biomedica completes deal with Homology Medicines to set up 1st US subsidiary | N/A | |
| 2022-02-23 00:19 EST | News | Homology Medicines downgraded to perform at Oppenheimer on clinical hold | N/A | |
| 2022-02-19 11:10 EST | News | Homology Medicines sinks on FDA clinical hold for phenylketonuria trial | N/A | |
| 2022-01-28 07:31 EST | News | Oxford Biomedica inks deal with Homology Medicines to expand viral vector offerings | N/A | |
| 2021-11-16 01:02 EST | News | Homology Medicines EPS beats by $0.08, beats on revenue | N/A | |
| 2021-10-22 07:34 EST | News | Homology Medicines: In Vivo Gene Therapy Platform With Delayed Lead Trial Coming Back Online | N/A | |
| 2021-10-18 13:16 EST | News | Homology Medicines initiates early-stage HMI-203 Hunter syndrome trial | N/A | |
| 2021-10-13 00:46 EST | News | Homology Medicines to start clinical trial for gene editing candidate in phenylketonuria | N/A | |
| 2021-09-23 02:55 EST | News | FIXX, DTIL, EAR and SYBX among after hours movers | N/A | |
| 2021-08-12 17:04 EST | News | Homology Medicines EPS beats by $0.06, beats on revenue | N/A | |
| 2021-07-21 09:04 EST | News | LMNL, CLAR, FIXX and PETS among after-hours movers | N/A | |
| 2021-05-07 08:14 EST | News | Homology Medicines EPS beats by $0.62, beats on revenue | N/A | |
| 2021-04-06 20:50 EST | News | Homology Medicines proposes $50M capital raise | N/A | |
| 2021-03-12 11:37 EST | Earnings Estimate | An EPS average of -$2.35 is estimated for the 2022 year. | Sell | |
| 2021-03-12 11:37 EST | Earnings Estimate | An EPS average of -$0.70 is estimated for the quarter ending on June 30, 2021. | Sell | |
| 2021-03-12 07:41 EST | Financials | Company financials have been released. | Neutral | |
| 2021-03-03 07:47 EST | Analyst Rating | The Analyst Target Price has decreased from $28.44 to $27. | Neutral | |
| 2021-01-18 03:39 EST | Analyst Rating | The Analyst Target Price has decreased from $29 to $28.44. | Neutral | |
| 2021-01-06 20:35 EST | News | Homology Medicines unveils plans to start three gene therapy programs this year | N/A | |
| 2020-12-22 19:59 EST | News | Homology Medicines: $60 Million Pfizer Equity-Investment, 4 Encouraging Candidates, And Competent Management | N/A | |
| 2020-11-26 20:01 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-11 11:51 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-11 11:51 EST | Earnings Estimate | An EPS average of -$0.76 is estimated for the quarter ending on March 31, 2021. | Sell | |
| 2020-11-11 11:51 EST | Analyst Rating | The Analyst Target Price has decreased from $29.56 to $29. | Neutral | |
| 2020-11-10 13:40 EST | News | Homology Medicines nabs investment from Pfizer | N/A | |
| 2020-11-10 13:39 EST | News | Homology Medicines EPS beats by $0.18, beats on revenue | N/A | |
| 2020-11-07 15:50 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 08:18 EST | News | Homology Medicines slumps on gene therapy data in inherited metabolic disorder | N/A | |
| 2020-10-22 22:54 EST | News | Homology Medicines unveils gene therapy program for rare metabolic disorder | N/A | |
| 2020-10-07 17:49 EST | News | Homology Medicines (FIXX) Investor Presentation - Slideshow | N/A | |
| 2020-10-07 08:47 EST | Analyst Rating | The Analyst Target Price has decreased from $30.22 to $29.56. | Neutral | |
| 2020-09-26 12:46 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 04:54 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-17 00:45 EST | Analyst Rating | The Analyst Target Price has decreased from $31 to $30.22. | Neutral | |
| 2020-08-14 08:49 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-12 04:47 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-12 04:47 EST | Analyst Rating | The Analyst Target Price has decreased from $32.22 to $31. | Neutral | |
| 2020-08-11 13:58 EST | News | Homology Medicines EPS misses by $0.02, revenue in-line | N/A | |
| 2020-07-31 01:00 EST | Financials | Company financials have been released. | Neutral | |
About Homology Medicines, Inc (FIXX):
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing across a range of genetic disorders. The company's various set of AAVHSCs allows company to target, through a single injection, a range of disease-relevant tissues, including the liver, central nervous system, peripheral nervous system, bone marrow, muscle, and eye. Its lead product candidate is HMI-102, which is in Phase I/II pheNIX clinical trial, a gene therapy for the treatment of phenylketonuria (PKU) in adults. The company also develops HMI-103 for the treatment of PKU in pediatric patients; HMI-202 to treat metachromatic leukodystrophy; and HMI-203 for the treatment of mucopolysaccharidosis type II. Homology Medicines, Inc. was incorporated in 2015 and is based in Bedford, Massachusetts.
General
- Name Homology Medicines, Inc
- Symbol FIXX
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 205
- Fiscal Year EndDecember
- IPO Date2018-03-28
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.homologymedicines.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 174.16
- Price/Book (Most Recent Quarter) 2.64
- Enterprise Value Revenue 116.77
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$2.70
- Next Year EPS Estimate -$2.60
- Next Quarter EPS Estimate -$0.67
- Operating Margin -4821%
- Return on Assets -28%
- Return on Equity -57%
- Revenue 2.7 million
- Earnings Per Share -$2.18
- Revenue Per Share $0.06
- Gross Profit -97690000
- Quarterly Earnings Growth 74.1%
View More
Highlights
- Market Capitalization 509.92 million
- EBITDA -86802000
- PE Ratio -0.48
- Analyst Target Price $27
- Book Value Per Share $3.90
View More
Share Statistics
- Shares Outstanding 50.49 million
- Shares Float 29.56 million
- % Held by Insiders 1645%
- % Held by Institutions 89.82%
- Shares Short 2.03 million
- Shares Short Prior Month 2.09 million
- Short Ratio 5.46
- Short % of Float 6%
- Short % of Shares Outstanding 4%
View More
Technicals
- Beta -0.29
- 52 Week High $19.4
- 52 Week Low $8.82
- 50 Day Moving Average 11.79
- 200 Day Moving Average 11.21
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Homology Medicines, Inc (FIXX) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Homology Medicines, Inc (FIXX) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-03-11 | $980000 | -$0.62 | -$0.65 | 5.24% |
| 2020-09-30 | 2020-11-09 | $N/A | -$0.62 | -$0.80 | 22.22% |
| 2020-06-30 | 2020-08-10 | $N/A | -$0.78 | -$0.76 | -2.79% |
| 2020-03-31 | 2020-05-07 | $588000 | -$0.78 | -$0.66 | -18.18% |
| 2019-12-31 | 2020-03-12 | $563000 | -$0.55 | -$0.68 | 19.51% |
| 2019-09-30 | 2019-11-12 | $441000 | -$0.67 | -$0.59 | -13.18% |
| 2019-06-30 | 2019-08-08 | $392000 | -$0.61 | -$0.55 | -10.91% |
| 2019-03-31 | 2019-05-13 | $270000 | -$0.64 | -$0.54 | -18.52% |
| 2018-12-31 | 2019-03-12 | $980002 | -$0.52 | -$0.44 | -18.18% |
| 2018-09-30 | 2018-11-13 | $954149 | -$0.40 | -$0.36 | -12.14% |
| 2018-06-30 | 2018-08-13 | $926477 | -$0.35 | -$0.32 | -9.38% |
| 2018-03-31 | 2018-05-14 | $823372 | -$4.21 | -$2.84 | -48.24% |
Homology Medicines, Inc (FIXX) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Homology Medicines, Inc (FIXX) Chart:
Homology Medicines, Inc (FIXX) News:
Below you will find a list of latest news for Homology Medicines, Inc (FIXX) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Homology Medicines, Inc (FIXX) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2024-05-17 | 2.5 | 0.1 | CALL | 10 | 177 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 7.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 2.5 | 1.5 | PUT | 1 | 1 | 0 | TRUE | 0 | 0 |
| 2024-05-17 | 5 | 0 | PUT | 0 | 0 | 244.76 | TRUE | 0 | 0 |
| 2024-05-17 | 7.5 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-07-19 | 2.5 | 0.1 | CALL | 5 | 152 | 0 | FALSE | 0 | 0 |
| 2024-07-19 | 5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-07-19 | 7.5 | 0.1 | CALL | 0 | 2 | 0 | FALSE | 0 | 0 |
| 2024-07-19 | 2.5 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-07-19 | 5 | 0 | PUT | 0 | 0 | 180.55 | TRUE | 0 | 0 |
| 2024-07-19 | 7.5 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-10-18 | 2.5 | 0.1 | CALL | 3 | 107 | 0 | FALSE | 0 | 0 |
| 2024-10-18 | 5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-10-18 | 7.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-10-18 | 2.5 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-10-18 | 5 | 0 | PUT | 0 | 0 | 147.4 | TRUE | 0 | 0 |
| 2024-10-18 | 7.5 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2030-12-18 | 10 | 2.2 | CALL | 14 | 510 | 0 | FALSE | 0.45 | 0.26 |
| 2030-12-18 | 5 | 1.55 | PUT | 1 | 2 | 0 | TRUE | 0.12 | 0.08 |
Latest FIXX Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 100 | $1.935 |
| Jun 13, 2022 7:59 PM EST | 4 | $1.935 |
| Jun 13, 2022 7:59 PM EST | 1 | $1.935 |
| Jun 13, 2022 7:59 PM EST | 9 | $1.935 |
| Jun 13, 2022 7:59 PM EST | 391 | $1.935 |
Homology Medicines, Inc (FIXX) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924320016398/0000899243-20-016398-index.htm |
| 2019-04-08 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1661998/000000000019006752/0000000000-19-006752-index.htm |
| 2020-01-15 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1661998/000001961720000098/0000019617-20-000098-index.htm |
| 2020-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1661998/000008025520001321/0000080255-20-001321-index.htm |
| 2019-02-13 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1661998/000031506619001101/0000315066-19-001101-index.htm |
| 2020-02-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1661998/000031506620001042/0000315066-20-001042-index.htm |
| 2018-04-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924318009444/0000899243-18-009444-index.htm |
| 2018-04-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924318009445/0000899243-18-009445-index.htm |
| 2018-04-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924318009446/0000899243-18-009446-index.htm |
| 2018-04-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924318009447/0000899243-18-009447-index.htm |
| 2018-04-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924318009459/0000899243-18-009459-index.htm |
| 2018-04-04 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924318009495/0000899243-18-009495-index.htm |
| 2018-05-16 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924318013061/0000899243-18-013061-index.htm |
| 2018-09-27 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924318025449/0000899243-18-025449-index.htm |
| 2018-12-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924318031340/0000899243-18-031340-index.htm |
| 2018-12-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924318031342/0000899243-18-031342-index.htm |
| 2018-12-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924318031344/0000899243-18-031344-index.htm |
| 2018-12-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924318031346/0000899243-18-031346-index.htm |
| 2019-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924319015642/0000899243-19-015642-index.htm |
| 2019-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924319015645/0000899243-19-015645-index.htm |
| 2019-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924319015647/0000899243-19-015647-index.htm |
| 2019-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924319015650/0000899243-19-015650-index.htm |
| 2019-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924319015653/0000899243-19-015653-index.htm |
| 2019-06-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924319016221/0000899243-19-016221-index.htm |
| 2019-06-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924319016223/0000899243-19-016223-index.htm |
| 2019-06-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924319016224/0000899243-19-016224-index.htm |
| 2019-06-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924319016226/0000899243-19-016226-index.htm |
| 2019-06-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924319016227/0000899243-19-016227-index.htm |
| 2019-06-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924319016228/0000899243-19-016228-index.htm |
| 2019-06-11 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924319016520/0000899243-19-016520-index.htm |
| 2019-07-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924319019172/0000899243-19-019172-index.htm |
| 2019-07-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924319019175/0000899243-19-019175-index.htm |
| 2019-07-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924319019182/0000899243-19-019182-index.htm |
| 2019-07-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924319019474/0000899243-19-019474-index.htm |
| 2019-07-15 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924319019624/0000899243-19-019624-index.htm |
| 2019-07-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924319019625/0000899243-19-019625-index.htm |
| 2019-08-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924319020990/0000899243-19-020990-index.htm |
| 2019-08-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924319020992/0000899243-19-020992-index.htm |
| 2019-08-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924319020993/0000899243-19-020993-index.htm |
| 2019-09-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924319022839/0000899243-19-022839-index.htm |
| 2019-09-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924319022840/0000899243-19-022840-index.htm |
| 2019-09-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924319022841/0000899243-19-022841-index.htm |
| 2019-09-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924319023114/0000899243-19-023114-index.htm |
| 2019-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924319024656/0000899243-19-024656-index.htm |
| 2019-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924319024657/0000899243-19-024657-index.htm |
| 2019-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924319024658/0000899243-19-024658-index.htm |
| 2019-12-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924319028392/0000899243-19-028392-index.htm |
| 2019-12-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924319028394/0000899243-19-028394-index.htm |
| 2019-12-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924319028395/0000899243-19-028395-index.htm |
| 2019-12-03 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924319028396/0000899243-19-028396-index.htm |
| 2019-12-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924319028397/0000899243-19-028397-index.htm |
| 2019-12-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924319029153/0000899243-19-029153-index.htm |
| 2019-12-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924319029154/0000899243-19-029154-index.htm |
| 2019-12-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924319029156/0000899243-19-029156-index.htm |
| 2019-12-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924319029157/0000899243-19-029157-index.htm |
| 2019-12-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924319029158/0000899243-19-029158-index.htm |
| 2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924320000313/0000899243-20-000313-index.htm |
| 2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924320000314/0000899243-20-000314-index.htm |
| 2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924320000316/0000899243-20-000316-index.htm |
| 2020-01-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924320002311/0000899243-20-002311-index.htm |
| 2020-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924320003246/0000899243-20-003246-index.htm |
| 2020-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924320003248/0000899243-20-003248-index.htm |
| 2020-03-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924320008885/0000899243-20-008885-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924320016388/0000899243-20-016388-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924320016390/0000899243-20-016390-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924320016391/0000899243-20-016391-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924320016392/0000899243-20-016392-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924320016395/0000899243-20-016395-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924320016398/0000899243-20-016398-index.htm |
| 2020-07-21 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924320019812/0000899243-20-019812-index.htm |
| 2020-07-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000089924320019813/0000899243-20-019813-index.htm |
| 2019-05-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000101297519000390/0001012975-19-000390-index.htm |
| 2019-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1661998/000107261319000105/0001072613-19-000105-index.htm |
| 2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1661998/000107261320000098/0001072613-20-000098-index.htm |
| 2018-04-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000110465918022462/0001104659-18-022462-index.htm |
| 2018-11-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000110465918069431/0001104659-18-069431-index.htm |
| 2018-11-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000110465918069432/0001104659-18-069432-index.htm |
| 2018-11-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000110465918070148/0001104659-18-070148-index.htm |
| 2018-11-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000110465918070149/0001104659-18-070149-index.htm |
| 2018-12-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000110465918072618/0001104659-18-072618-index.htm |
| 2018-12-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000110465918072619/0001104659-18-072619-index.htm |
| 2019-02-04 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1661998/000110465919005517/0001104659-19-005517-index.htm |
| 2019-02-13 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1661998/000110465919007932/0001104659-19-007932-index.htm |
| 2019-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000110465919030565/0001104659-19-030565-index.htm |
| 2019-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000110465919030566/0001104659-19-030566-index.htm |
| 2020-02-06 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1661998/000110465920011469/0001104659-20-011469-index.htm |
| 2020-03-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1661998/000110465920031227/0001104659-20-031227-index.htm |
| 2018-04-11 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1661998/000119312518114234/0001193125-18-114234-index.htm |
| 2019-04-01 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1661998/000119312519094628/0001193125-19-094628-index.htm |
| 2019-04-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1661998/000119312519094758/0001193125-19-094758-index.htm |
| 2019-04-08 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1661998/000119312519100527/0001193125-19-100527-index.htm |
| 2019-04-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1661998/000119312519100789/0001193125-19-100789-index.htm |
| 2019-04-08 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1661998/000119312519100794/0001193125-19-100794-index.htm |
| 2019-04-10 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1661998/000119312519102942/0001193125-19-102942-index.htm |
| 2019-04-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1661998/000119312519103880/0001193125-19-103880-index.htm |
| 2019-04-25 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1661998/000119312519119853/0001193125-19-119853-index.htm |
| 2019-04-25 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1661998/000119312519119871/0001193125-19-119871-index.htm |
| 2019-06-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1661998/000119312519169173/0001193125-19-169173-index.htm |
| 2019-06-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1661998/000119312519184386/0001193125-19-184386-index.htm |
| 2019-07-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1661998/000119312519194114/0001193125-19-194114-index.htm |
| 2019-12-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1661998/000119312519318478/0001193125-19-318478-index.htm |
| 2020-03-12 | S-3ASR | Automatic shelf registration statement of securities of well-known seasoned issuers | https://www.sec.gov/Archives/edgar/data/1661998/000119312520071690/0001193125-20-071690-index.htm |
| 2020-06-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1661998/000119312520166769/0001193125-20-166769-index.htm |
| 2020-07-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1661998/000119312520196449/0001193125-20-196449-index.htm |
| 2018-04-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000119380518000506/0001193805-18-000506-index.htm |
| 2018-04-06 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1661998/000119380518000516/0001193805-18-000516-index.htm |
| 2019-04-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000119380519000360/0001193805-19-000360-index.htm |
| 2019-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000119380519000567/0001193805-19-000567-index.htm |
| 2019-12-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000119380519001976/0001193805-19-001976-index.htm |
| 2019-12-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000119380519001981/0001193805-19-001981-index.htm |
| 2019-12-30 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1661998/000119380519001984/0001193805-19-001984-index.htm |
| 2020-01-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000119380520000076/0001193805-20-000076-index.htm |
| 2020-01-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1661998/000119380520000087/0001193805-20-000087-index.htm |
| 2020-01-31 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1661998/000119380520000088/0001193805-20-000088-index.htm |
| 2020-04-20 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1661998/000119380520000496/0001193805-20-000496-index.htm |
| 2020-05-01 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1661998/000119380520000541/0001193805-20-000541-index.htm |
| 2019-12-30 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1661998/000149315219019826/0001493152-19-019826-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1661998/000149315220002397/0001493152-20-002397-index.htm |
| 2018-05-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1661998/000156459018013403/0001564590-18-013403-index.htm |
| 2018-08-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1661998/000156459018021456/0001564590-18-021456-index.htm |
| 2018-11-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1661998/000156459018029297/0001564590-18-029297-index.htm |
| 2019-03-12 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1661998/000156459019007250/0001564590-19-007250-index.htm |
| 2019-05-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1661998/000156459019018819/0001564590-19-018819-index.htm |
| 2019-08-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1661998/000156459019030748/0001564590-19-030748-index.htm |
| 2019-11-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1661998/000156459019042892/0001564590-19-042892-index.htm |
| 2020-03-12 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1661998/000156459020010441/0001564590-20-010441-index.htm |
| 2020-04-28 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1661998/000156459020019187/0001564590-20-019187-index.htm |
| 2020-04-28 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1661998/000156459020019197/0001564590-20-019197-index.htm |
| 2020-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1661998/000156459020022819/0001564590-20-022819-index.htm |
| 2020-08-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1661998/000156459020038900/0001564590-20-038900-index.htm |
| 2019-01-10 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1661998/000156761919000962/0001567619-19-000962-index.htm |
| 2019-04-09 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1661998/999999999519000651/9999999995-19-000651-index.htm |
Homology Medicines, Inc (FIXX) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Homology Medicines, Inc (FIXX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 1645%Institutional Ownership: 8982%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-01-30 | James E Flynn | 10% Share Holder | Sell | 509,970.00 | 15.45 | 7,879,036.50 | 0.00 | https://www.sec.gov/Archives/edgar/data/1661998/000119380520000087/0001193805-20-000087-index.htm |
| 2019-06-03 | Timothy P Kelly | Officer | Sell | 1,288.00 | 20.00 | 25,764.89 | 0.00 | https://www.sec.gov/Archives/edgar/data/1661998/000089924319015650/0000899243-19-015650-index.htm |
| 2019-09-05 | Timothy P Kelly | Officer | Sell | 1,166.00 | 19.94 | 23,251.44 | 0.00 | https://www.sec.gov/Archives/edgar/data/1661998/000089924319023114/0000899243-19-023114-index.htm |
| 2020-03-17 | Timothy P Kelly | Officer | Sell | 1,315.00 | 13.01 | 17,108.54 | 0.00 | https://www.sec.gov/Archives/edgar/data/1661998/000089924320008885/0000899243-20-008885-index.htm |
| 2019-06-03 | W Bradford Smith | CFO, Treasurer & Secretary | Sell | 6,000.00 | 19.94 | 119,664.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1661998/000089924319015653/0000899243-19-015653-index.htm |
| 2019-07-01 | W Bradford Smith | CFO, Treasurer & Secretary | Sell | 6,000.00 | 19.00 | 113,971.20 | 0.00 | https://www.sec.gov/Archives/edgar/data/1661998/000089924319019175/0000899243-19-019175-index.htm |
| 2019-08-01 | W Bradford Smith | CFO, Treasurer & Secretary | Sell | 6,000.00 | 17.37 | 104,190.60 | 0.00 | https://www.sec.gov/Archives/edgar/data/1661998/000089924319020992/0000899243-19-020992-index.htm |
| 2019-09-03 | W Bradford Smith | CFO, Treasurer & Secretary | Sell | 6,000.00 | 18.74 | 112,419.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1661998/000089924319022841/0000899243-19-022841-index.htm |
| 2019-10-01 | W Bradford Smith | CFO, Treasurer & Secretary | Sell | 100.00 | 18.23 | 1,823.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1661998/000089924319024658/0000899243-19-024658-index.htm |
| 2019-11-29 | W Bradford Smith | CFO, Treasurer & Secretary | Sell | 6,000.00 | 16.00 | 96,000.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1661998/000089924319028395/0000899243-19-028395-index.htm |
| 2019-12-02 | W Bradford Smith | CFO, Treasurer & Secretary | Sell | 6,000.00 | 16.21 | 97,266.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1661998/000089924319028395/0000899243-19-028395-index.htm |
| 2020-01-02 | W Bradford Smith | CFO, Treasurer & Secretary | Sell | 6,000.00 | 20.50 | 122,984.40 | 0.00 | https://www.sec.gov/Archives/edgar/data/1661998/000089924320000313/0000899243-20-000313-index.htm |
| 2020-02-03 | W Bradford Smith | CFO, Treasurer & Secretary | Sell | 12,000.00 | 16.16 | 193,866.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1661998/000089924320003248/0000899243-20-003248-index.htm |
| 2019-10-01 | W Bradford Smith | CFO, Treasurer & Secretary | Sell | 5,900.00 | 17.38 | 102,543.77 | 100.00 | https://www.sec.gov/Archives/edgar/data/1661998/000089924319024658/0000899243-19-024658-index.htm |
| 2019-12-02 | ARTHUR TZIANABOS | President & CEO | Sell | 12,500.00 | 16.25 | 203,176.25 | 102,505.00 | https://www.sec.gov/Archives/edgar/data/1661998/000089924319028394/0000899243-19-028394-index.htm |
| 2019-11-18 | Richard J. Gregory | Director | Buy | 10,806.00 | 0.03 | 324.18 | 10,806.00 | https://www.sec.gov/Archives/edgar/data/1661998/000089924320002311/0000899243-20-002311-index.htm |
| 2019-11-29 | ARTHUR TZIANABOS | President & CEO | Sell | 12,500.00 | 16.04 | 200,558.75 | 115,005.00 | https://www.sec.gov/Archives/edgar/data/1661998/000089924319028394/0000899243-19-028394-index.htm |
| 2019-04-12 | James E Flynn | Director | Buy | 533,333.00 | 22.50 | 11,999,992.50 | 1,158,333.00 | https://www.sec.gov/Archives/edgar/data/1661998/000119380519000360/0001193805-19-000360-index.htm |
| 2018-04-02 | MAHENDRA SHAH | Director | Buy | 500,000.00 | 16.00 | 8,000,000.00 | 1,159,742.00 | https://www.sec.gov/Archives/edgar/data/1661998/000089924318009459/0000899243-18-009459-index.htm |
| 2020-02-03 | W Bradford Smith | CFO, Treasurer & Secretary | Buy | 12,000.00 | 0.63 | 7,579.20 | 12,000.00 | https://www.sec.gov/Archives/edgar/data/1661998/000089924320003248/0000899243-20-003248-index.htm |
| 2019-10-01 | ARTHUR TZIANABOS | President & CEO | Sell | 100.00 | 18.23 | 1,823.00 | 127,505.00 | https://www.sec.gov/Archives/edgar/data/1661998/000089924319024657/0000899243-19-024657-index.htm |
| 2019-10-01 | ARTHUR TZIANABOS | President & CEO | Sell | 12,400.00 | 17.39 | 215,644.68 | 127,605.00 | https://www.sec.gov/Archives/edgar/data/1661998/000089924319024657/0000899243-19-024657-index.htm |
| 2019-09-03 | ARTHUR TZIANABOS | President & CEO | Sell | 12,500.00 | 18.75 | 234,320.00 | 140,005.00 | https://www.sec.gov/Archives/edgar/data/1661998/000089924319022839/0000899243-19-022839-index.htm |
| 2019-08-01 | ARTHUR TZIANABOS | President & CEO | Sell | 12,500.00 | 17.37 | 217,111.25 | 152,505.00 | https://www.sec.gov/Archives/edgar/data/1661998/000089924319020990/0000899243-19-020990-index.htm |
| 2020-01-02 | Albert Seymour | Chief Scientific Officer | Sell | 9,133.00 | 20.50 | 187,216.45 | 154,017.00 | https://www.sec.gov/Archives/edgar/data/1661998/000089924320000314/0000899243-20-000314-index.htm |
| 2019-12-02 | Albert Seymour | Chief Scientific Officer | Sell | 9,300.00 | 16.23 | 150,969.69 | 163,150.00 | https://www.sec.gov/Archives/edgar/data/1661998/000089924319028392/0000899243-19-028392-index.htm |
| 2019-07-01 | ARTHUR TZIANABOS | President & CEO | Sell | 12,500.00 | 18.98 | 237,300.00 | 165,005.00 | https://www.sec.gov/Archives/edgar/data/1661998/000089924319019172/0000899243-19-019172-index.htm |
| 2019-11-29 | Albert Seymour | Chief Scientific Officer | Sell | 9,300.00 | 16.06 | 149,389.62 | 172,450.00 | https://www.sec.gov/Archives/edgar/data/1661998/000089924319028392/0000899243-19-028392-index.htm |
| 2019-12-24 | James E Flynn | 10% Share Holder | Sell | 151,233.00 | 21.95 | 3,319,579.47 | 1,766,106.00 | https://www.sec.gov/Archives/edgar/data/1661998/000119380519001981/0001193805-19-001981-index.htm |
| 2019-06-03 | ARTHUR TZIANABOS | President & CEO | Sell | 12,500.00 | 19.86 | 248,262.50 | 177,505.00 | https://www.sec.gov/Archives/edgar/data/1661998/000089924319015645/0000899243-19-015645-index.htm |
| 2019-10-01 | Albert Seymour | Chief Scientific Officer | Sell | 100.00 | 18.23 | 1,823.00 | 181,750.00 | https://www.sec.gov/Archives/edgar/data/1661998/000089924319024656/0000899243-19-024656-index.htm |
| 2019-10-01 | Albert Seymour | Chief Scientific Officer | Sell | 9,200.00 | 17.38 | 159,936.48 | 181,850.00 | https://www.sec.gov/Archives/edgar/data/1661998/000089924319024656/0000899243-19-024656-index.htm |
| 2019-09-03 | Albert Seymour | Chief Scientific Officer | Sell | 9,300.00 | 18.74 | 174,283.86 | 191,050.00 | https://www.sec.gov/Archives/edgar/data/1661998/000089924319022840/0000899243-19-022840-index.htm |
| 2019-12-23 | James E Flynn | 10% Share Holder | Sell | 56,595.00 | 21.83 | 1,235,434.89 | 1,917,339.00 | https://www.sec.gov/Archives/edgar/data/1661998/000119380519001976/0001193805-19-001976-index.htm |
| 2019-12-20 | James E Flynn | 10% Share Holder | Sell | 9,130.00 | 21.50 | 196,296.83 | 1,973,934.00 | https://www.sec.gov/Archives/edgar/data/1661998/000119380519001976/0001193805-19-001976-index.htm |
| 2019-12-19 | James E Flynn | 10% Share Holder | Sell | 5,454.00 | 21.68 | 118,218.72 | 1,983,064.00 | https://www.sec.gov/Archives/edgar/data/1661998/000119380519001976/0001193805-19-001976-index.htm |
| 2019-08-01 | Albert Seymour | Chief Scientific Officer | Sell | 9,300.00 | 17.37 | 161,523.33 | 200,350.00 | https://www.sec.gov/Archives/edgar/data/1661998/000089924319020993/0000899243-19-020993-index.htm |
| 2019-07-01 | Albert Seymour | Chief Scientific Officer | Sell | 100.00 | 19.56 | 1,956.00 | 209,650.00 | https://www.sec.gov/Archives/edgar/data/1661998/000089924319019182/0000899243-19-019182-index.htm |
| 2019-07-01 | Albert Seymour | Chief Scientific Officer | Sell | 9,200.00 | 18.98 | 174,582.88 | 209,750.00 | https://www.sec.gov/Archives/edgar/data/1661998/000089924319019182/0000899243-19-019182-index.htm |
| 2019-06-03 | Albert Seymour | Chief Scientific Officer | Sell | 9,300.00 | 19.90 | 185,093.25 | 218,950.00 | https://www.sec.gov/Archives/edgar/data/1661998/000089924319015647/0000899243-19-015647-index.htm |
| 2019-05-16 | 5AM Ventures IV, L.P. | 10% Share Holder | Sell | 24,600.00 | 21.47 | 528,162.00 | 221,435.00 | https://www.sec.gov/Archives/edgar/data/1661998/000110465919030566/0001104659-19-030566-index.htm |
| 2019-05-16 | KUSH PARMAR | Director | Sell | 24,600.00 | 21.47 | 528,162.00 | 221,435.00 | https://www.sec.gov/Archives/edgar/data/1661998/000110465919030565/0001104659-19-030565-index.htm |
| 2019-07-09 | Siyamak Rasty | Chief Operating Officer | Sell | 8,000.00 | 20.00 | 160,000.00 | 222,707.00 | https://www.sec.gov/Archives/edgar/data/1661998/000089924319019474/0000899243-19-019474-index.htm |
| 2019-06-03 | Siyamak Rasty | Chief Operating Officer | Sell | 8,000.00 | 20.22 | 161,777.60 | 230,707.00 | https://www.sec.gov/Archives/edgar/data/1661998/000089924319015642/0000899243-19-015642-index.htm |
| 2019-12-24 | James E Flynn | 10% Share Holder | Sell | 198,767.00 | 21.95 | 4,362,955.53 | 2,321,199.00 | https://www.sec.gov/Archives/edgar/data/1661998/000119380519001981/0001193805-19-001981-index.htm |
| 2018-12-10 | 5AM Ventures IV, L.P. | 10% Share Holder | Sell | 623.00 | 26.01 | 16,201.18 | 246,035.00 | https://www.sec.gov/Archives/edgar/data/1661998/000110465918072619/0001104659-18-072619-index.htm |
| 2018-12-10 | KUSH PARMAR | Director | Sell | 623.00 | 26.01 | 16,201.18 | 246,035.00 | https://www.sec.gov/Archives/edgar/data/1661998/000110465918072618/0001104659-18-072618-index.htm |
| 2018-11-23 | 5AM Ventures IV, L.P. | 10% Share Holder | Sell | 1,187.00 | 20.04 | 23,782.73 | 246,658.00 | https://www.sec.gov/Archives/edgar/data/1661998/000110465918070148/0001104659-18-070148-index.htm |
| 2018-11-23 | KUSH PARMAR | Director | Sell | 1,187.00 | 20.04 | 23,782.73 | 246,658.00 | https://www.sec.gov/Archives/edgar/data/1661998/000110465918070149/0001104659-18-070149-index.htm |
| 2018-11-16 | 5AM Ventures IV, L.P. | 10% Share Holder | Sell | 21,036.00 | 20.20 | 424,927.20 | 247,845.00 | https://www.sec.gov/Archives/edgar/data/1661998/000110465918069431/0001104659-18-069431-index.htm |
| 2018-11-16 | KUSH PARMAR | Director | Sell | 21,036.00 | 20.20 | 424,927.20 | 247,845.00 | https://www.sec.gov/Archives/edgar/data/1661998/000110465918069432/0001104659-18-069432-index.htm |
| 2019-12-23 | James E Flynn | 10% Share Holder | Sell | 74,384.00 | 21.83 | 1,623,758.09 | 2,519,966.00 | https://www.sec.gov/Archives/edgar/data/1661998/000119380519001976/0001193805-19-001976-index.htm |
| 2019-12-20 | James E Flynn | 10% Share Holder | Sell | 11,999.00 | 21.50 | 257,980.90 | 2,594,350.00 | https://www.sec.gov/Archives/edgar/data/1661998/000119380519001976/0001193805-19-001976-index.htm |
| 2019-12-19 | James E Flynn | 10% Share Holder | Sell | 7,168.00 | 21.68 | 155,370.70 | 2,606,349.00 | https://www.sec.gov/Archives/edgar/data/1661998/000119380519001976/0001193805-19-001976-index.htm |
| 2018-04-02 | James E Flynn | Director | Buy | 625,000.00 | 16.00 | 10,000,000.00 | 2,613,517.00 | https://www.sec.gov/Archives/edgar/data/1661998/000119380518000506/0001193805-18-000506-index.htm |
| 2020-01-29 | James E Flynn | 10% Share Holder | Sell | 8,857.00 | 15.45 | 136,807.88 | 509,970.00 | https://www.sec.gov/Archives/edgar/data/1661998/000119380520000087/0001193805-20-000087-index.htm |
| 2020-01-28 | James E Flynn | 10% Share Holder | Sell | 65,891.00 | 15.51 | 1,021,936.46 | 518,827.00 | https://www.sec.gov/Archives/edgar/data/1661998/000119380520000076/0001193805-20-000076-index.htm |
| 2019-05-16 | 5AM Ventures IV, L.P. | 10% Share Holder | Sell | 590,400.00 | 21.47 | 12,675,888.00 | 5,314,484.00 | https://www.sec.gov/Archives/edgar/data/1661998/000110465919030566/0001104659-19-030566-index.htm |
| 2019-05-16 | KUSH PARMAR | Director | Sell | 590,400.00 | 21.47 | 12,675,888.00 | 5,314,484.00 | https://www.sec.gov/Archives/edgar/data/1661998/000110465919030565/0001104659-19-030565-index.htm |
| 2020-01-27 | James E Flynn | 10% Share Holder | Sell | 193,359.00 | 15.77 | 3,049,600.14 | 584,718.00 | https://www.sec.gov/Archives/edgar/data/1661998/000119380520000076/0001193805-20-000076-index.htm |
| 2018-12-10 | 5AM Ventures IV, L.P. | 10% Share Holder | Sell | 14,952.00 | 26.01 | 388,828.26 | 5,904,884.00 | https://www.sec.gov/Archives/edgar/data/1661998/000110465918072619/0001104659-18-072619-index.htm |
| 2018-12-10 | KUSH PARMAR | Director | Sell | 14,952.00 | 26.01 | 388,828.26 | 5,904,884.00 | https://www.sec.gov/Archives/edgar/data/1661998/000110465918072618/0001104659-18-072618-index.htm |
| 2018-11-23 | 5AM Ventures IV, L.P. | 10% Share Holder | Sell | 28,495.00 | 20.04 | 570,925.82 | 5,919,836.00 | https://www.sec.gov/Archives/edgar/data/1661998/000110465918070148/0001104659-18-070148-index.htm |
| 2018-11-23 | KUSH PARMAR | Director | Sell | 28,495.00 | 20.04 | 570,925.82 | 5,919,836.00 | https://www.sec.gov/Archives/edgar/data/1661998/000110465918070149/0001104659-18-070149-index.htm |
| 2018-11-16 | 5AM Ventures IV, L.P. | 10% Share Holder | Sell | 504,864.00 | 20.20 | 10,198,252.80 | 5,948,331.00 | https://www.sec.gov/Archives/edgar/data/1661998/000110465918069431/0001104659-18-069431-index.htm |
| 2018-11-16 | KUSH PARMAR | Director | Sell | 504,864.00 | 20.20 | 10,198,252.80 | 5,948,331.00 | https://www.sec.gov/Archives/edgar/data/1661998/000110465918069432/0001104659-18-069432-index.htm |
| 2019-06-03 | W Bradford Smith | CFO, Treasurer & Secretary | Buy | 6,000.00 | 0.64 | 3,840.00 | 6,000.00 | https://www.sec.gov/Archives/edgar/data/1661998/000089924319015653/0000899243-19-015653-index.htm |
| 2019-07-01 | W Bradford Smith | CFO, Treasurer & Secretary | Buy | 6,000.00 | 0.64 | 3,840.00 | 6,000.00 | https://www.sec.gov/Archives/edgar/data/1661998/000089924319019175/0000899243-19-019175-index.htm |
| 2019-08-01 | W Bradford Smith | CFO, Treasurer & Secretary | Buy | 6,000.00 | 0.64 | 3,840.00 | 6,000.00 | https://www.sec.gov/Archives/edgar/data/1661998/000089924319020992/0000899243-19-020992-index.htm |
| 2019-09-03 | W Bradford Smith | CFO, Treasurer & Secretary | Buy | 6,000.00 | 0.64 | 3,840.00 | 6,000.00 | https://www.sec.gov/Archives/edgar/data/1661998/000089924319022841/0000899243-19-022841-index.htm |
| 2019-10-01 | W Bradford Smith | CFO, Treasurer & Secretary | Buy | 6,000.00 | 0.64 | 3,840.00 | 6,000.00 | https://www.sec.gov/Archives/edgar/data/1661998/000089924319024658/0000899243-19-024658-index.htm |
| 2019-11-29 | W Bradford Smith | CFO, Treasurer & Secretary | Buy | 6,000.00 | 0.64 | 3,840.00 | 6,000.00 | https://www.sec.gov/Archives/edgar/data/1661998/000089924319028395/0000899243-19-028395-index.htm |
| 2019-12-02 | W Bradford Smith | CFO, Treasurer & Secretary | Buy | 6,000.00 | 0.64 | 3,840.00 | 6,000.00 | https://www.sec.gov/Archives/edgar/data/1661998/000089924319028395/0000899243-19-028395-index.htm |
| 2020-01-02 | W Bradford Smith | CFO, Treasurer & Secretary | Buy | 6,000.00 | 0.63 | 3,789.60 | 6,000.00 | https://www.sec.gov/Archives/edgar/data/1661998/000089924320000313/0000899243-20-000313-index.htm |
| 2018-04-02 | James E Flynn | Director | Buy | 625,000.00 | 16.00 | 10,000,000.00 | 625,000.00 | https://www.sec.gov/Archives/edgar/data/1661998/000119380518000506/0001193805-18-000506-index.htm |
| 2020-02-03 | ARTHUR TZIANABOS | President & CEO | Sell | 12,500.00 | 16.16 | 202,021.25 | 77,505.00 | https://www.sec.gov/Archives/edgar/data/1661998/000089924320003246/0000899243-20-003246-index.htm |
| 2020-01-24 | James E Flynn | 10% Share Holder | Sell | 380,256.00 | 15.69 | 5,964,999.82 | 778,077.00 | https://www.sec.gov/Archives/edgar/data/1661998/000119380520000076/0001193805-20-000076-index.htm |
| 2020-01-02 | ARTHUR TZIANABOS | President & CEO | Sell | 12,500.00 | 20.50 | 256,191.25 | 90,005.00 | https://www.sec.gov/Archives/edgar/data/1661998/000089924320000316/0000899243-20-000316-index.htm |